» Authors » Patrick M McCarthy

Patrick M McCarthy

Explore the profile of Patrick M McCarthy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 352
Citations 6525
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Adams D, Tang G, Whisenant B, Kodali S, Singh G, Fam N, et al.
JACC Cardiovasc Interv . 2024 Dec; 17(23):2749-2760. PMID: 39663056
Background: Untreated severe tricuspid regurgitation (TR) carries a poor prognosis. Objectives: The authors report the 1-year outcomes of transcatheter edge-to-edge repair (TEER) with the TriClip system (Abbott Structural Heart) in...
2.
Tang G, Hahn R, Whisenant B, Hamid N, Naik H, Makkar R, et al.
J Am Coll Cardiol . 2024 Oct; 85(3):235-246. PMID: 39471883
Background: Tricuspid regurgitation (TR) is a right-sided valvular disease independently associated with morbidity and mortality. The TRILUMINATE Pivotal (Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid...
3.
Whitlock R, McCarthy P, Gerdisch M, Ramlawi B, Alexander J, Sultan I, et al.
Am Heart J . 2024 Oct; 284:94-102. PMID: 39395566
Introduction: Left atrial appendage exclusion (LAAE) has been shown in randomized trials to reduce ischemic stroke risk in patients undergoing cardiac surgery with known atrial fibrillation (AF). Many patients undergoing...
4.
Van Decar S, Carpenter E, Adams A, Chick R, Clifton G, Stojadinovic A, et al.
Cancer Treat Res Commun . 2024 Sep; 41:100843. PMID: 39305541
Background: The autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine is produced from dendritic cells (DC) loaded ex vivo with autologous tumor lysate (TL). TLPLDC has been shown to decrease...
5.
Baudo M, Sicouri S, Yamashita Y, Senzai M, McCarthy P, Gerdisch M, et al.
Circ Cardiovasc Interv . 2024 Sep; 17(10):e014296. PMID: 39258365
Background: The role of left atrial appendage occlusion (LAAO) in patients without previous atrial fibrillation (AF) is not established. This meta-analysis was conducted on patients with normal sinus rhythm who...
6.
Jorde U, Benza R, McCarthy P, Ailawadi G, Whisenant B, Makkar R, et al.
J Am Coll Cardiol . 2024 Sep; 84(25):2446-2456. PMID: 39222896
Background: The TRILUMINATE Pivotal trial is a prospective, randomized, controlled study of patients with severe tricuspid regurgitation (TR). Venous congestion due to TR may lead to end-organ dysfunction and failure....
7.
Nedadur R, Bhatt N, Liu T, Chu M, McCarthy P, Kline A
Can J Cardiol . 2024 Aug; 40(10):1865-1879. PMID: 39098601
Artificial Intelligence (AI) has greatly affected our everyday lives and holds great promise to change the landscape of medicine. AI is particularly positioned to improve care for the increasingly complex...
8.
Sirset-Becker T, Clark A, Flaherty J, Mehta C, Allen B, McCarthy P, et al.
J Thorac Cardiovasc Surg . 2024 Jul; PMID: 38950772
Objective: Aortic root replacement requires construction of a composite valve-graft and reimplantation of coronary arteries. This study assessed the feasibility of valve-in-valve transcatheter aortic valve implantation after aortic root replacement....
9.
Johnston D, Mehta C, Malaisrie S, Baldridge A, Pham D, Bryner B, et al.
Ann Cardiothorac Surg . 2024 Jun; 13(3):275-282. PMID: 38841084
Background: The desire of patients to avoid anticoagulation, together with the potential of valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR), have resulted in the increasing use of bioprosthetic valves for...
10.
Carpenter E, Van Decar S, McCarthy P, Valdera F, Adams A, OShea A, et al.
J Surg Oncol . 2024 May; 130(1):109-116. PMID: 38801055
Background: The benefit of adjuvant therapy (AT) remains unclear in pancreatic ductal adenocarcinoma (PDAC) after neoadjuvant therapy (NAT) and surgical resection. Methods: The 2019 National Cancer Database was queried for...